Mucormycosis is an opportunistic fulminant fungal infection, which mainly infects immunocompromised patients. Infection with mucormycosis can cause devastating rhino-orbital-cerebral and pulmonary infection with an extremely poor prognosis. The infection begins in the nose and paranasal sinuses due to inhalation of fungal spores. We report a case of mucormycosis in an uncontrolled diabetic pati...

Mucormycosis is a rare Angioinvasive fungal infection that is commonly seen in immunosuppressed patients with reported mortality rates of 95% in disseminated diseases.1 The disease is caused by the Filamentous fungi of the Mucorales Order (class of Zygomycetes)1 Renal Mucormycosis is a manifestation of disseminated diseases. Isolated renal mucormycosis is extremely rare, only few cases have bee...

Gastrointestinal (GI) mucormycosis is a rare and life-threatening invasive fungal infection. GI mucormycosis occur in all parts of the alimentary tract, with the stomach being the most common site. Diabetes mellitus and other types of conditions associated with immunodeficiency, including hematologic malignancies, solid organ transplantation and glucocorticoid therapy, are risk factors for GI m...

BACKGROUND Mucormycosis is a rare but devastating fungal infection primarily affecting immunocompromised patients such as those with hematological malignancy, bone marrow and solid organ transplantation, and patients with diabetes, and, even more rarely, immunocompetent patients. The objective of this study was to assess the prevalence and burden, both clinical and economic, of mucormycosis amo...

Recent therapeutic advances have the potential to improve outcomes of mucormycosis. Lipid formulations of amphotericin B (LFAB) have evolved as the cornerstone of primary therapy for mucormycosis. Posaconazole may be useful as salvage therapy, but it cannot be recommended as primary therapy for mucormycosis on the basis of available data. Preclinical and limited retrospective clinical data sugg...

Mucormycosis is a rare opportunistic devastating fungal infection, which usually occurs in immunocompromised patients. Mucormycosis has multiple presentations that the predilection for one of these presentations varies with the either underlying or predisposing condition. We present a case of pulmonary and rhinocerberal mucormycosis in 56-year-old man with diabetic ketoacidosis.

mucormycosis is a clinical entity attributed to opportunistic fungal infection of order mucorales. this includes several pathogenic subtypes. it commonly affects the rhinocerebral sites and the immunocompromized patients with devastating results. visceral mucormycosis is a relatively rare complication. we report the first free sigmoid colon perforation secondary to invasive mucormycosis and dis...

Mucormycosis of the neonatal gut is a rare disease, with uniformly fatal prognosis. It has occasionally been reported involving the stomach and ileum in immunocompromised hosts. However, mucormycosis of the colon is very rare. We report case of a preterm, low birth weight (LBW) neonate with clinical features of Necrotising enterocolitis found to have characteristic black-velvety colonic gangren...

Mucormycosis is an uncommon acute and often fatal opportunistic fungal infection that is classically seen with poorly controlled diabetes mellitus with acidosis, acute leukemia, or other immunosuppressive conditions. A relatively new association of mucormycosis occurring in patients with iron and aluminum excess who receive deferoxamine therapy has been reported with increasing frequency. While...